Pancreatic Insufficiency Clinical Trials
2 recruiting trials for Pancreatic Insufficiency. Eligibility criteria explained in plain English.
2
Total Trials
2
Recruiting Now
0
Phase 3 Trials
1
Sponsors
Recruiting Trials
RECRUITINGPhase 1NCT06995651
Dorzagliatin in Pancreatic Insufficient Cystic Fibrosis
This study is designed to determine the pharmacokinetic and pharmacodynamic response of dorzagliatin 75 mg twice daily following 7-day administration in individuals with...
Sponsor: University of PennsylvaniaEnrolling: 152 locations
RECRUITINGPhase 2NCT04731272
GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance
Diabetes is a major co-morbidity in pancreatic insufficient cystic fibrosis (PI-CF) and associated with worse outcomes. While reduced β-cell mass contributes to the insulin...
Sponsor: University of PennsylvaniaEnrolling: 302 locations